MedPath

Study of the glucose metabolism-improving effect of the 12-week intake of beverages containing lactic acid bacteria

Phase 2
Conditions
Hyperglycemia
Registration Number
JPRN-UMIN000023466
Lead Sponsor
HUMA R&D CORP
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
130
Inclusion Criteria

Not provided

Exclusion Criteria

1. Subjects in the drug therapy or in the hospital care 2. Sever systemic diseases affecting the results of this study 3. Subjects with an immunodeficiency 4. Subjects with a previous history or merger of malignant tumors 5. Subjects in pregnancy or in nursing 6. Subjects with a habit of intake more than twice in a week of fermented milk or lactic fermenting beverage in three months before screening test 7. Constant use of oral medication or supplements affecting glucese or lipid matabolism in three months before screening test 8. Subjects with food allergy or medicine allergy 9. Subjects who drink a lot of alcohol 10. Subjects who participated in other clinical trials within one month before the agreement of participants in this study 11. Subjects who are judged as unsuitable for the study by the investigator for other reasons

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fasted blood glucose level Glycoalbumin Insulin resistance index
Secondary Outcome Measures
NameTimeMethod
Blood fat level Body fat percentage Blood inflammatory cytokines
© Copyright 2025. All Rights Reserved by MedPath